ATPase H+ Transporting V0 Subunit C Pseudogene 3: A Promising Drug Target and Biomarker

Target Name: ATP6V0CP3

NCBI ID: G442211

ATP6V0CP3

Other Name(s): ATPase H+ transporting V0 subunit c pseudogene 3

ATPase H+ Transporting V0 Subunit C Pseudogene 3: A Promising Drug Target and Biomarker

ATP (adenosine triphosphate) is a crucial molecule in cellular metabolism, as it stores and transfers energy within the cell. The ATPase H+ transporting V0 subunit c pseudogene 3 (ATPase H+ transporting V0 subunit c gene, or ATPase H+ transporting V0 subunit c) is a gene that encodes a protein involved in ATPase H+ transporting, which is a critical process for maintaining cellular homeostasis and survival.

ATPase H+ transporting V0 subunit c pseudogene 3 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. In this article, we will explore the biology of ATPase H+ transporting V0 subunit c pseudogene 3, its potential as a drug target, and its potential as a biomarker for various diseases.

Potential Drug Target

ATPase H+ transporting V0 subunit c pseudogene 3 is a protein that plays a critical role in maintaining cellular homeostasis and has been implicated in various diseases. Its function in ATPase H+ transporting has been studied extensively, and several studies have identified its potential as a drug target.

One of the key reasons for the potential of ATPase H+ transporting V0 subunit c pseudogene 3 as a drug target is its involvement in the regulation of cellular signaling pathways. ATPase H+ transporting V0 subunit c pseudogene 3 has been shown to play a critical role in the regulation of the Na+/K+-ATPase signaling pathway, which is involved in a wide range of physiological processes, including muscle contractions, nerve function, and brain function.

In addition to its involvement in cellular signaling pathways, ATPase H+ transporting V0 subunit c pseudogene 3 has also been shown to play a critical role in the regulation of cellular processes that are important for disease development, such as cancer progression and neurodegenerative diseases.

Potential Biomarker

ATPase H+ transporting V0 subunit c pseudogene 3 has also been identified as a potential biomarker for various diseases. Its involvement in the regulation of cellular signaling pathways makes it an attractive target for the development of diagnostic tools and therapies.

Studies have shown that changes in the expression of ATPase H+ transporting V0 subunit c pseudogene 3 are associated with a wide range of diseases, including cancer, neurodegenerative diseases, and respiratory diseases. For example, studies have shown that decreased expression of ATPase H+ transporting V0 subunit c pseudogene 3 is associated with increased cancer risk and decreased survival in neurodegenerative diseases.

In addition, studies have also shown that changes in the expression of ATPase H+ transporting V0 subunit c pseudogene 3 are associated with respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma.

Conclusion

In conclusion, ATPase H+ transporting V0 subunit c pseudogene 3 is a gene that has the potential to be a drug target and biomarker for a wide range of diseases. Its involvement in cellular signaling pathways and its association with various diseases make it an attractive target for research and development of new therapies and diagnostic tools. Further studies are needed to fully understand its role in disease and its potential as a drug target and biomarker.

Protein Name: ATPase H+ Transporting V0 Subunit C Pseudogene 3

The "ATP6V0CP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP6V0CP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets